China Pharma Holdings Announces Reverse Stock Split
Company Announcements

China Pharma Holdings Announces Reverse Stock Split

China Pharma Holdings (CPHI) has released an update.

China Pharma Holdings, Inc. announced a 1-for-5 reverse stock split scheduled to take effect on March 6, 2024. This adjustment means that every five shares of existing stock will be consolidated into one new share. The change will start with the opening of the market on the effective date, with all shares having the same par value of $0.001. This strategic move aims to restructure the company’s stock for improved market performance.

For further insights into CPHI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyChina Pharma subsidiary plans to launch dry eye treatment in Q1 of 2025 in China
TheFlyChina Pharma to implement 1-for-5 reverse stock split
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App